Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia

被引:27
作者
Sowmya, S. [1 ]
Manjari, K. Sri [1 ]
Ramaiah, A. [3 ]
Sunitha, T. [1 ]
Nallari, P. [2 ]
Jyothy, A. [1 ]
Venkateshwari, A. [1 ]
机构
[1] Osmania Univ, Inst Genet & Hosp Genet Dis, Hyderabad 500016, Andhra Pradesh, India
[2] Osmania Univ, Dept Genet, Hyderabad 500016, Andhra Pradesh, India
[3] Govt Matern Hosp, Hyderabad, Andhra Pradesh, India
关键词
haplotype; interleukin-10; pre-eclampsia; reproductive immunology; Th1/Th2; CYTOKINE PRODUCTION; SUCCESSFUL PREGNANCY; IL-10; ASSOCIATION; CYTOTROPHOBLASTS; IMPLANTATION; STIMULATION; DEFICIENCY; HAPLOTYPES; INVASION;
D O I
10.1111/cei.12402
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pre-eclampsia is one of the most serious disorders of human pregnancy and T helper type 1 (Th1)/Th2 imbalance plays a major role in its aetiology. The Th2 cytokine, interleukin (IL)-10, plays a significant role in the maintenance of pregnancy. The present study is aimed at understanding the role of IL-10 promoter polymorphisms (-1082 G/A; -592 A/C and -819 C/T) and their haplotypes in early-onset pre-eclampsia. A total of 120 patients and an equal number of women with normal pregnancy, from Government Maternity Hospital, Petlaburz, Hyderabad, India, were considered for the present study. A standard amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) was carried out for genotyping followed by agarose gel electrophoresis. Appropriate statistical methods were applied to test for the significance of the results. It was found that the IL-10 -819 C allele (P = 0.003) and -592 A (P = 0.005) allele frequencies increased significantly in patients compared to controls. No significant difference was found with regard to -1082 promoter polymorphism. Haplotype analysis of the IL-10 single nucleotide polymorphisms (SNPs) revealed a significant association with ACC haplotype with a twofold increased risk in patients compared to controls. The frequencies of two common IL-10 haplotypes (GCC and ATA) did not show any significant difference. Further, the diplotype analysis revealed five genotypes: -1082A with -819C (P = 0.0016); -1082G with -819C (P = 0.0018); -819C with -592C (P = 0.001); -1082A with -592C (P = 0.032); and -1082G with -592C (P = 0.005) associated with the disease. These findings support the concept of contribution of IL-10 gene polymorphisms in the pathogenesis of early-onset pre-eclampsia.
引用
收藏
页码:334 / 341
页数:8
相关论文
共 46 条
[1]   Haploview: analysis and visualization of LD and haplotype maps [J].
Barrett, JC ;
Fry, B ;
Maller, J ;
Daly, MJ .
BIOINFORMATICS, 2005, 21 (02) :263-265
[2]   Inflammation and pre-eclampsia [J].
Borzychowski, A. M. ;
Sargent, I. L. ;
Redman, C. W. G. .
SEMINARS IN FETAL & NEONATAL MEDICINE, 2006, 11 (05) :309-316
[3]   Analysis of the 5′ flanking region of the interleukin 10 gene in patients with systemic sclerosis [J].
Crilly, A ;
Hamilton, J ;
Clark, CJ ;
Jardine, A ;
Madhok, R .
RHEUMATOLOGY, 2003, 42 (11) :1295-1298
[4]   New polymorphisms in the IL-10 promoter region [J].
D'Alfonso, S ;
Rampi, M ;
Rolando, V ;
Giordano, M ;
Momigliano-Richiardi, P .
GENES AND IMMUNITY, 2000, 1 (03) :231-233
[5]   EXTRACELLULAR MATRIX-5 - ADHESIVE INTERACTIONS IN EARLY MAMMALIAN EMBRYOGENESIS, IMPLANTATION, AND PLACENTATION [J].
DAMSKY, C ;
SUTHERLAND, A ;
FISHER, S .
FASEB JOURNAL, 1993, 7 (14) :1320-1329
[6]   Interleukin 10-2849AA genotype protects against pre-eclampsia [J].
de Groot, CJM ;
Jansen, MWJC ;
Bertina, RM ;
Schonkeren, JJM ;
Helmerhorst, F ;
Huizinga, TWJ .
GENES AND IMMUNITY, 2004, 5 (04) :313-314
[7]   Interleukin 10 secretion in relation to human IL-10 locus haplotypes [J].
Eskdale, J ;
Gallagher, G ;
Verweij, CL ;
Keijsers, V ;
Westendorp, RGJ ;
Huizinga, TWJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9465-9470
[8]   Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence [J].
Eskdale, J ;
Kube, D ;
Tesch, H ;
Gallagher, G .
IMMUNOGENETICS, 1997, 46 (02) :120-128
[9]  
GHILDYAL N, 1992, J BIOL CHEM, V267, P8473
[10]  
Hennessy A, 1999, J IMMUNOL, V163, P3491